S5059
Referred to committee
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
- Federal
- Senate
- Introduced Jul 21, 2026
- Session 119
Bill Text
The full text for this bill hasn't been synced yet.
Read it on Congress.govLegislative Timeline
2 actions-
Introduced in Senate
-
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.